Table 2.
Biomarkers significantly associated with physical outcome after ischemic stroke by time after stroke
| Time after stroke | Biomarker associated with physical outcome | Article Reference Numbers | |||
|---|---|---|---|---|---|
|
| |||||
| Immune response | Lipids/Metabolism | Neuronal function | Blood vessel/Circulation | ||
| 1 month | CRP, WBC | Cholesterol, LDL-C | CrCl, D-Dimer, Fibrinogen, Hematocrit, Hemoglobin, Troponin | [49,61] | |
| 3 months | Adiponectin, CCL11, Copeptin, CRP, GDF-15, IL-1β, IL-1Ra, IL-6, IL-8, IL-10, IL-12, MCP1, Osteopontin, TNFα | Glucose, HDL-C | BDNF, Glutamate, GOT, GPT | Endostatin, eGFR, Fibrinogen, Fibronectin, MR-proANP, proMMP-10 | [28-31,37,38,54-60] |
| 6 months | CCL11 | Glucose | [39,56] | ||
BDNF = Brain-derived neurotrophic factor; CCL11 = C-C motif chemokine 11; CrCl = Creatinine Clearance; CRP = C-reactive protein; eGFR = Estimated glomerular filtration rate; GDF-15 = Growth Differentiation Factor-15; GOT = Glutamic oxaloacetic transaminase; GPT = Glutamic pyruvic transaminase; HDL-C = High-density lipoprotein cholesterol; IL = Interleukin; LDL-C = Low-density lipoprotein cholesterol; MCP1 = Monocyte chemoattractant protein 1; MMP = Matrix Metalloproteinase; MR-proANP = Midregional proatrial natriuretic peptide; TNFα = Tumor necrosis factor-alpha; WBC = White blood cell.